Brief: India's Tatva Chintan Pharma Chem Mar-Quarter Consol Net Profit Falls
May 5 (Reuters) - Tatva Chintan Pharma Chem Ltd
TATV.NS :
* MAR-QUARTER CONSOL NET PROFIT 169.5 MILLION RUPEES VERSUS
PROFIT
175.1 MILLION RUPEES
* MAR-QUARTER CONSOL REVENUE FROM OPERATIONS 1.25 BILLION
RUPEES
VERSUS 985.3 MILLION RUPEES
* DIVIDEND OF 2 RUPEES PER SHARE
Source text for Eikon: ID:nBSE3G6wRl
Further company coverage: TATV.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tatva Chintan Pharma Chem
See all newsIndia's Tatva Chintan Pharma Chem rises as ICICI Securities raises target price
Brief: Tatva Chintan Pharma Chem Says Sept-Quarter Consol Net Profit 214.51 Million Rupees
India's Tatva Chintan Pharma hits upper circuit as Q1 profit more than doubles
Brief: Tatva Chintan Pharma Chem Sept Quarter Consol Net Profit 99.2 Million Rupees
India's Tatva Chintan Pharma Chem soars on Q1 profit jump